课题基金 / 基金详情

Salt Mediated Cross Talk Between Lymphatic Vessels and Immune Cells in Kidney Disease

Salt Mediated Cross Talk Between Lymphatic Vessels and Immune Cells in Kidney Disease
盐介导肾脏疾病中淋巴管和免疫细胞之间的交互作用
批准号:
10636755
负责人:
VALENTINA KON
金额:
$76.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-02 至 2028-04-30

项目摘要

项目成果

VALENTINA KON的其他基金

相似基金

相关文献

中文摘要
翻译
总结
英文摘要
SUMMARY Lymphatic vessels are essential to maintaining interstitial fluid homeostasis, immune cell trafficking and antigen clearance. Ineffectual clearance due to inadequate lymphatic transport is a key promoter of many diseases that reflects insufficient number, reabsorptive capacity and contractility of the lymphatic vascular network. In contrast to blood vessels, lymphatic vessels are exquisitely sensitive to interstitial elements, including Na+ which is a powerful regulator of lymphatic growth in hypertensive settings. Our studies in hypertensive settings, have found Na+ activates the highly reactive lipid oxidation product, isolevuglandin (IsoLG) in antigen presenting immune cells (APCs) via the epithelial Na+ channel (ENaC). Our new data reveal proteinuric kidney disease increases intrarenal Na+ and thus establish a high Na+ environment within the kidney parenchyma. Like ENaC in immune cells, Na+, not osmolality, modulates expression of the sodium potassium chloride co-transporter (NKCC1) in lymphatic endothelial cells (LECs). Proteinuric animals as well as humans have elevated levels of urinary IsoLG adducted to apolipoprotein AI (apoAI) best known for its role in inflammation, oxidative stress, and cholesterol handling in atherosclerotic heart disease. Although kidney disease manifests all co-morbidities linked to modified apoAI, little is understood about these effects on kidneys. We show for the first time that kidney injury promotes intrarenal IsoLG and that IsoLG-apoAI upregulates NKCC1 in LECs. Together, our published and preliminary data support the hypothesis that kidney injury leads to renal Na+ accumulation which stimulates lymphangiogenesis, activates LECs, weakens lymphatic dynamics that encourages immune cell trafficking into the renal interstitium through mechanisms that involve Na+ sensing via NKCC1 and IsoLG uptake by LECs. Our studies will define how intrarenal Na+ accumulation modulates the lymphatic network and crosstalk between renal lymphatics and activated immune cells which we postulate promote interstitial stagnation of potentially harmful molecules and cells and subsequent tubulointerstitial fibrosis. To test this hypothesis, we propose three mechanistic aims. Aim 1 will test the hypothesis that that injury-driven accumulation of Na+ in renal interstitium directly disrupts the structure and function of the renal lymphatic network via a IsoLG-NKCC1 pathway. Aim 2 will define how Na+ activated immune cells involve IsoLG and vasoconstricting endothelins to impair renal lymphatics thereby increasing renal interstitial stagnation. In Aim 3 we will determine that activated monocytes with high IsoLG from humans with CKD blunt lymphangiogenesis and weaken lymphatic pumping that promotes progressive kidney fibrosis in humanized mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modified Intestinal apoAI-particles and Lymphatics Accelerate CKD-driven CVD
Modified Intestinal apoAI-particles and Lymphatics Accelerate CKD-driven CVD
Modified Intestinal apoAI-particles and Lymphatics Accelerate CKD-driven CVD
Role of Macrophage-Specific AT1R in Atherosclerosis of Chronic Kidney Dysfunction
  • 批准号:
    8256798
  • 项目类别:
  • 资助金额:
    $37.99万
  • 财政年份:
    2008
  • 负责人:
    VALENTINA KON
  • 依托单位:
海外基金